MIS-C Treatment: Is IVIG Always Necessary?
- PMID: 34805048
- PMCID: PMC8595395
- DOI: 10.3389/fped.2021.753123
MIS-C Treatment: Is IVIG Always Necessary?
Erratum in
-
Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?Front Pediatr. 2022 Feb 14;9:826518. doi: 10.3389/fped.2021.826518. eCollection 2021. Front Pediatr. 2022. PMID: 35237545 Free PMC article.
Abstract
Background: MIS-C is a potentially severe inflammatory syndrome associated with SARS-CoV-2 exposure. Intravenous immunoglobulin (IVIG) is considered the first-tier therapy, but it implies infusion of large fluid volumes that may worsen cardiac function. Patients and Methods: Since April 2020, we have developed a treatment protocol that avoids the infusion of IVIG as first-line therapy in the early phase of MIS-C. In this study, we retrospectively analyzed a cohort of consecutive patients treated according to this protocol between 01/04/2020 and 01/04/2021. Results: In the last year, 31 patients have been treated according to the protocol: 25 with high-dose pulse MP (10 mg/kg) and 6 with 2 mg/kg. 67.7% of the patients responded to the initial treatment, while the others needed a step-up, either with Anakinra (25.8%) or with MP dose increase (6.5%). IVIG was administered in four patients. Overall, only one patient (3.2%) needed ICU admission and inotropic support; one patient developed a small coronary artery aneurysm. Conclusions: Timely start of MP therapy and careful fluid management might improve the outcomes of MIS-C patients.
Keywords: IVIG (intravenous immunoglobulin) administration; MIS-C; SARS-CoV-2; steroid; therapy.
Copyright © 2021 Licciardi, Baldini, Dellepiane, Covizzi, Mogni, Pruccoli, Orsi, Rabbone, Parodi, Mignone and Montin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. . American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. (2020) 72:1791–805. 10.1002/ART.41454 - DOI - PMC - PubMed
-
- Popolazione per età, sessoe stato civile 2020 - Piemonte . Available online at: https://www.tuttitalia.it/piemonte/statistiche/popolazione-eta-sesso-sta... (accessed September 30, 2021).
LinkOut - more resources
Full Text Sources
Miscellaneous
